Catalogue Search | MBRL
Are you sure you want to remove the book from the shelf?
{{itemTitle}}
224
result(s) for
"Forbes, David L"
Sort by:
Studying management critically
Drawing upon a range of influential contemporary movements in the social sciences such as the Critical Theory of the Frankfurt School, this text provides a wide-ranging analysis of management and its various specialisms. The book offers critical understandings of key areas of management theory and practice such as: accounting; strategic management; marketing; business ethics; and environmental management. The leading international contributors also examine: - the relations between power and discursive practices in the modern corporation - the role of architecture as a repressive and emancipatory force in organizations - gender and organizations and critical methodology for organizational research. Key issues of power/knowledge relations across these areas are addressed and new agendas both for these fields and for management studies as a whole are introduced. Contributing authors include: Mats Alvesson, Gibson Burrell, David Cooper, Karen Dale, Stan Deetz, Linda Forbes, John Forester, John Jermier, David Levy, Joanne Martin, Glenn Morgan, Martin Parker, Mike Power, Richard Loughlin and Hugh Willmott.
eBook
Exploiting chemistry and molecular systems for quantum information science
The power of chemistry to prepare new molecules and materials has driven the quest for new approaches to solve problems having global societal impact, such as in renewable energy, healthcare and information science. In the latter case, the intrinsic quantum nature of the electronic, nuclear and spin degrees of freedom in molecules offers intriguing new possibilities to advance the emerging field of quantum information science. In this Perspective, which resulted from discussions by the co-authors at a US Department of Energy workshop held in November 2018, we discuss how chemical systems and reactions can impact quantum computing, communication and sensing. Hierarchical molecular design and synthesis, from small molecules to supramolecular assemblies, combined with new spectroscopic probes of quantum coherence and theoretical modelling of complex systems, offer a broad range of possibilities to realize practical quantum information science applications.
Molecular design and synthesis, from small molecules to supramolecular assemblies, combined with new spectroscopic probes of quantum coherence and theoretical modelling, offer a broad range of possibilities to realize practical quantum information science applications in computing, communications and sensing.
Journal Article
Orbital angular momentum of twisted light: chirality and optical activity
Optical activity is conventionally understood as a natural difference in the optical responses of chiral materials with opposite handedness. It stems from the quantised spin angular momentum ± ħ per photon, with the ± representing either left- or right-handed circular polarisations. Less well known, until recently, was the possibility that matter might also respond in a similar, discriminatory way to the handedness of twisted light, or ‘optical vortices’, whose orbital angular momentum (OAM) is quantised as ℓ ℏ per photon, where ℓ is the topological charge whose sign determines a wavefront twist to the left or right. Initial studies focusing on whether, in spectroscopic applications, chiral matter might respond differently to the vortex handedness of + ℓ and − ℓ beams, failed to identify any viable mechanism. However, in the last few years, theory and experiment have both supplied ample evidence that, under certain conditions, such forms of interaction do exist—and as a result, the field of chirality and optical OAM is beginning to flourish at a pace. This topical review presents a survey of this new field, working up from a description of those initial studies to the cutting-edge experiments now taking place. Analysing the fundamental mechanisms provides for a revision of previous precepts, broadening their scope in the light of recent advances in understanding, and highlighting a vibrant synergy between the fields of optical activity and twisted light.
Journal Article
Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?
Background:
There are wide international differences in 1-year cancer survival. The UK and Denmark perform poorly compared with other high-income countries with similar health care systems: Australia, Canada and Sweden have good cancer survival rates, Norway intermediate survival rates. The objective of this study was to examine the pattern of differences in cancer awareness and beliefs across these countries to identify where these might contribute to the pattern of survival.
Methods:
We carried out a population-based telephone interview survey of 19 079 men and women aged ⩾50 years in Australia, Canada, Denmark, Norway, Sweden and the UK using the Awareness and Beliefs about Cancer measure.
Results:
Awareness that the risk of cancer increased with age was lower in the UK (14%), Canada (13%) and Australia (16%) but was higher in Denmark (25%), Norway (29%) and Sweden (38%). Symptom awareness was no lower in the UK and Denmark than other countries. Perceived barriers to symptomatic presentation were highest in the UK, in particular being worried about wasting the doctor's time (UK 34%; Canada 21%; Australia 14%; Denmark 12%; Norway 11%; Sweden 9%).
Conclusion:
The UK had low awareness of age-related risk and the highest perceived barriers to symptomatic presentation, but symptom awareness in the UK did not differ from other countries. Denmark had higher awareness of age-related risk and few perceived barriers to symptomatic presentation. This suggests that other factors must be involved in explaining Denmark's poor survival rates. In the UK, interventions that address barriers to prompt presentation in primary care should be developed and evaluated.
Journal Article
Effect of massed v. standard prolonged exposure therapy on PTSD in military personnel and veterans: a non-inferiority randomised controlled trial
A short, effective therapy for posttraumatic stress disorder (PTSD) could decrease barriers to implementation and uptake, reduce dropout, and ameliorate distressing symptoms in military personnel and veterans. This non-inferiority RCT evaluated the efficacy of 2-week massed prolonged exposure (MPE) therapy compared to standard 10-week prolonged exposure (SPE), the current gold standard treatment, in reducing PTSD severity in both active serving and veterans in a real-world health service system.
This single-blinded multi-site non-inferiority RCT took place in 12 health clinics across Australia. The primary outcome was PTSD symptom severity measured by the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) at 12 weeks. 138 military personnel and veterans with PTSD were randomised. 71 participants were allocated to SPE, with 63 allocated to MPE.
The intention-to-treat sample included 138 participants, data were analysed for 134 participants (88.1% male,
= 46 years). The difference between the mean MPE and SPE group PTSD scores from baseline to 12 weeks-post therapy was 0.94 [95% confidence interval (CI) -4.19 to +6.07]. The upper endpoint of the 95% CI was below +7, indicating MPE was non-inferior to SPE. Significant rates of loss of PTSD diagnosis were found for both groups (MPE 53.8%, SPE 54.1%). Dropout rates were 4.8% (MPE) and 16.9% (SPE).
MPE was non-inferior to SPE in significantly reducing symptoms of PTSD. Significant reductions in symptom severity, low dropout rates, and loss of diagnosis indicate MPE is a feasible, accessible, and effective treatment. Findings demonstrate novel methods to deliver gold-standard treatments for PTSD should be routinely considered.
Journal Article
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial
Cirrhosis is a major cause of morbidity and mortality; however, there are no approved therapies except orthotopic liver transplantation. Preclinical studies showed that bone-marrow-derived macrophage injections reduce inflammation, resolve fibrosis and stimulate liver regeneration. In a multicenter, open-label, parallel-group, phase 2 randomized controlled trial (
ISRCTN10368050
) in
n
= 51 adult patients with compensated cirrhosis and Model for End-Stage Liver Disease (MELD) score ≥10 and ≤17, we evaluated the efficacy of autologous monocyte-derived macrophage therapy (
n
= 27) compared to standard medical care (
n
= 24). The primary endpoint was the difference in baseline to day 90 change in MELD score (ΔMELD) between treatment and control groups (ΔΔMELD). Secondary endpoints included adverse clinical outcomes, non-invasive fibrosis biomarkers and health-related quality of life (HRQoL) at 90 d, 180 d and 360 d. The ΔΔMELD between day 0 and day 90 in the treatment group compared to controls was −0.87 (95% confidence interval: −1.79, 0.0;
P
= 0.06); therefore, the primary endpoint was not met. During 360-d follow-up, five of 24 participants in the control group developed a total of 10 severe adverse events, four of which were liver related, and three deaths (two liver related), whereas no liver-related severe adverse events or deaths occurred in the treatment group. Although no differences were observed in biomarkers or HRQoL, exploratory analysis showed anti-inflammatory serum cytokine profiles after macrophage infusion. This study reinforces the safety and potential efficacy of macrophage therapy in cirrhosis, supporting further investigation.
Results from the phase 2 MATCH01 clinical trial of autologous monocyte-derived macrophage therapy for liver cirrhosis revealed no liver-related severe adverse events or deaths in the treatment group.
Journal Article
Optical binding of nanoparticles
Optical binding is a laser-induced inter-particle force that exists between two or more particles subjected to off-resonant light. It is one of the key tools in optical manipulation of particles. Distinct from the single-particle forces which operate in optical trapping and tweezing, it enables the light-induced self-assembly of non-contact multi-particle arrays and structures. Whilst optical binding at the microscale between microparticles is well-established, it is only within the last few years that the experimental difficulties of observing nanoscale optical binding between nanoparticles have been overcome. This hurdle surmounted, there has been a sudden proliferation in observations of nanoscale optical binding, where the corresponding theoretical understanding and predictions of the underlying nanophotonics have become ever more important. This article covers these new developments, giving an overview of the emergent field of nanoscale optical binding.
Journal Article
CLN3 is required for the clearance of glycerophosphodiesters from lysosomes
Lysosomes have many roles, including degrading macromolecules and signalling to the nucleus
1
. Lysosomal dysfunction occurs in various human conditions, such as common neurodegenerative diseases and monogenic lysosomal storage disorders (LSDs)
2
–
4
. For most LSDs, the causal genes have been identified but, in some, the function of the implicated gene is unknown, in part because lysosomes occupy a small fraction of the cellular volume so that changes in lysosomal contents are difficult to detect. Here we develop the LysoTag mouse for the tissue-specific isolation of intact lysosomes that are compatible with the multimodal profiling of their contents. We used the LysoTag mouse to study CLN3, a lysosomal transmembrane protein with an unknown function. In children, the loss of
CLN3
causes juvenile neuronal ceroid lipofuscinosis (Batten disease), a lethal neurodegenerative LSD. Untargeted metabolite profiling of lysosomes from the brains of mice lacking CLN3 revealed a massive accumulation of glycerophosphodiesters (GPDs)—the end products of glycerophospholipid catabolism. GPDs also accumulate in the lysosomes of CLN3-deficient cultured cells and we show that CLN3 is required for their lysosomal egress. Loss of CLN3 also disrupts glycerophospholipid catabolism in the lysosome. Finally, we found elevated levels of glycerophosphoinositol in the cerebrospinal fluid of patients with Batten disease, suggesting the potential use of glycerophosphoinositol as a disease biomarker. Our results show that CLN3 is required for the lysosomal clearance of GPDs and reveal Batten disease as a neurodegenerative LSD with a defect in glycerophospholipid metabolism.
The lysosomal transmembrane protein CLN3 is required for the lysosomal clearance of glycerophosphodiesters in mice and in human cells, suggesting that the loss of CLN3 causes Batten disease in children due to defects in glycerophospholipid metabolism.
Journal Article
Dexamethasone and Surgical-Site Infection
In this trial involving patients undergoing noncardiac surgery, dexamethasone was noninferior to placebo with respect to the incidence of surgical-site infection within 30 days after surgery, including in patients with diabetes mellitus.
Journal Article